Novella

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• SemaglutideType not stated

What they publish

Novella publishes 1 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

States costs vary depending on individualised treatment plans and dosing requirements; no fixed figure published

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• The 15-22 percent figure sits at or above the upper end of what the major semaglutide trials reported — STEP 1 found a mean of about 14.9 percent at 68 weeks. Presenting that range as what 'many individuals' experience over six to nine months is optimistic framing.
• Trial averages come from supervised populations receiving structured lifestyle support alongside the drug, and individual results varied enormously.
• Pricing is individualised and not published, so cost cannot be compared.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Treat any specific outcome percentage as an average from a trial population, not a prediction for you.
• Establish the actual monthly cost before starting, since it is not published.
• Ask whether the semaglutide is FDA-approved or compounded.